Variation in treatment associated with life expectancy in a population-based cohort of men with early-stage prostate cancer
about
Nanoparticle-Enabled Selective Destruction of Prostate Tumor Using MRI-Guided Focal Photothermal Therapy.A hospital-based study of initial observation for low-risk prostate cancer and its predictors in the United StatesThe role of stereotactic body radiation therapy (SBRT) in the treatment of oligometastatic disease in the elderlyThe Quantitative Criteria Based on the Fractal Dimensions, Entropy, and Lacunarity for the Spatial Distribution of Cancer Cell Nuclei Enable Identification of Low or High Aggressive Prostate Carcinomas.Types of chronic conditions combinations and initial cancer treatment among elderly Medicare beneficiaries with localised prostate cancer.Influence of age on androgen deprivation therapy-associated Alzheimer's diseaseDoes true Gleason pattern 3 merit its cancer descriptor?A core outcome set for localised prostate cancer effectiveness trials.Comorbidity and age cannot explain variation in life expectancy associated with treatment of non-metastatic prostate cancer.Active surveillance in localized prostate cancer: comparison of incidental tumours (T1a/b) and tumours diagnosed by core needle biopsy (T1c/T2a): results from the HAROW study.Early effect of Medicare Shared Savings Program accountable care organization participation on prostate cancer care.Outcomes of patients older than 75 years with non-metastatic prostate cancer.Current impact of age and comorbidity assessment on prostate cancer treatment choice and over/undertreatment risk.
P2860
Q36023165-855B2FCF-F5C8-482E-8205-BC32547ED58DQ36414849-A42CE75C-AD80-4E60-9D38-1EB70D28D186Q36550917-AEAD23D0-C0DB-4C6D-897C-AB75B96D09DDQ36568781-ADC4F519-EF93-4B21-8DD8-D6C5D550EC63Q37053006-FBBB07FE-0007-4248-B222-DA6741B651D6Q37345771-70E27625-6A7B-482C-9400-618F9123BDFCQ38928930-8C860CFD-8287-47E6-A058-2C47CEE378CFQ39202486-985C924F-26CB-4E65-9113-25820EE66C57Q40504173-F5ACE815-7CE3-4233-B931-32E90FED4529Q48138982-5935B7C9-7A03-4741-BEED-965954F9DBDDQ48155304-FCA4DC70-DBD1-4464-97C4-D6DC598EF259Q52741575-9B384C6A-DCB2-4D8E-9EAA-F7FA8AB163F1Q53063187-8F7AF0D9-C38E-4BCE-B3F4-36F495C30E2B
P2860
Variation in treatment associated with life expectancy in a population-based cohort of men with early-stage prostate cancer
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Variation in treatment associa ...... th early-stage prostate cancer
@ast
Variation in treatment associa ...... th early-stage prostate cancer
@en
Variation in treatment associa ...... th early-stage prostate cancer
@nl
type
label
Variation in treatment associa ...... th early-stage prostate cancer
@ast
Variation in treatment associa ...... th early-stage prostate cancer
@en
Variation in treatment associa ...... th early-stage prostate cancer
@nl
prefLabel
Variation in treatment associa ...... th early-stage prostate cancer
@ast
Variation in treatment associa ...... th early-stage prostate cancer
@en
Variation in treatment associa ...... th early-stage prostate cancer
@nl
P2093
P2860
P356
P1433
P1476
Variation in treatment associa ...... th early-stage prostate cancer
@en
P2093
Andrew W Dick
Christopher Saigal
Claude M Setodji
Janet M Hanley
Mark S Litwin
Timothy J Daskivich
Urologic Diseases in America Project
P2860
P304
P356
10.1002/CNCR.28926
P407
P577
2014-07-17T00:00:00Z